RSS Feed  Les actualités de la BRVM en Flux RSS

NEWS FINANCIÈRES

Nous agrégeons les sources d’informations financières spécifiques Régionales et Internationales. Info Générale, Economique, Marchés Forex-Comodities- Actions-Obligataires-Taux, Vieille règlementaire etc.

Covid-19 vaccine: WB and AU join forces to support nearly 400 million people in Africa

22/06/2021
Categories: General Information

Enjoy a simplified experience

Find all the economic and financial information on our Orishas Direct application to download on Play Store

Work with countries and partners across Africa to rapidly expand equitable access to vaccines ; it is with this vision that the World Bank (WB) and the African Union (AU) are partnering to support the rapid immunization of nearly 400 million people in Africa.

 

African Finance Ministers and the World Bank Group met on Monday, June 21, 2021 to accelerate vaccine procurement on the continent and avoid a third wave. To boost the African Union's goal of vaccinating 60% of the continent's population by 2022, the two institutions announced that they are partnering to support the Africa Vaccine Procurement Task Force (AVATT) initiative with resources to enable countries to purchase and deploy vaccine procurement and deployment. vaccines for up to 400 million people across Africa. This extraordinary regional effort complements COVAX and comes at a time when COVID-19 cases are increasing in the region. Funding from the World Bank is available to support the purchase and deployment of AVATT-safe doses.

World Bank Group President David Malpass believes that by working together, institutions can  accelerate doses to countries and support deployment. Indeed, thanks to this initiative, the continent now has the capacity to vaccinate at least 400 million people, or 30% of the population of 1.3 billion. The aim of the Africa Vaccine Procurement Task Force, which is an initiative of the African Union Commission, Africa CDC, Afreximbank, AU Special Envoys for COVID-19 and ECA, is to provide the continent with sufficient and rapid access to COVID-19 vaccines. It has already successfully negotiated 220 million doses of Johnson & Johnson Janssen 'COVID-19 vaccine( J&J/Janssen) for use by African countries, with an option for an additional 180 million based on demand.

Provided by AWS Translate

0 COMMENTAIRE

Dans la même rubrique

12/09/2025 - Information générale

OF Brief matinal

11/09/2025 - Information générale

OF L'actualité en bref

11/09/2025 - Information générale

OF Brief matinal

10/09/2025 - Information générale

OF Brief matinal

09/09/2025 - Information générale

OF Brief matinal

08/09/2025 - Information générale

OF Brief matinal

05/09/2025 - Information générale

OF Brief matinal

04/09/2025 - Information générale

OF Brief matinal

Voir aussi

OF Brief  matinal

12/09/2025 - Information générale

OF Brief matinal
OF L'actualité en bref

11/09/2025 - Information générale

OF L'actualité en bref

Publicité